We dare to dream because we have what it takes to make a big idea — a reality.
Join us.


Harlan Krumholz, MD, SM

Harlan Krumholz, the Harold H. Hines, Jr. Professor of Medicine at Yale School of Medicine, is a cardiologist and the Director of the Center for Outcomes Research and Evaluation at Yale-New Haven Hospital, where he leads initiatives to improve the quality and outcomes of clinical decisions and healthcare delivery. He founded Hugo Health—to provide a patient-centric platform to engage people as partners in research and leverage the secure movement of digital health data—and is a founder of medRxiv, a preprint server for the medical and health sciences and co-founder of Refactor Health, an enterprise healthcare AI-augmented data management company. He is a member of the National Academy of Medicine, American Society for Clinical Investigation, and Association of American Physicians and was a member of the Advisory Committee to the Director of the National Institutes of Health. Dr. Krumholz received a BS from Yale, an MD from Harvard, and a Masters in Health Policy and Management from the Harvard School of Public Health.

Leslie New Round 2.png

Leslie Krumholz, JD

Leslie is a social entrepreneur who has spent decades working in the non profit sector focused on education and community development. Prior to joining Hugo, Leslie was founder and CEO of GoodStreets — one of Connecticut's first Benefit Corporations, a “Connecticut Tech Company to Watch” and recipient of the reSET Social Enterprise Award. Leslie was co-founder and director of two educational non-profit organizations and has provided leadership in transitional programming, fundraising and curriculum development for multiple community organizations. Leslie has a BA from the University of Massachusetts/Amherst and a JD from the University of California, Hastings College of the Law. She is a Connecticut Tech Council Women of Innovation Honoree.


Wade Schulz, MD, PhD
VP Technology

Wade is a clinical pathologist and physician scientist in the Department of Laboratory Medicine at Yale School of Medicine. His research focuses on computational healthcare, where he studies approaches to integrate, manage, and analyze large healthcare data sets, including real-time healthcare information, next generation sequencing, and other emerging healthcare data types. Dr. Schulz has led multiple big data and computational healthcare projects including the implementation of data science platforms, development of computer vision and artificial intelligence tools for physician decision support and dynamic modeling, and the integration and interoperability of electronic health record data. Dr. Schulz also collaborates on international initiatives that aim to use big data to improve population health and precision medicine, such as the China Million Persons Project. As Director of Technology at Hugo Health, Dr. Schulz leads strategic initiatives for technology research, development, and implementation.

dave_new round.jpg

Dave Hutten
VP Product

Dave comes to Hugo with a background in digital advertising. As Executive Producer at POSSIBLE, a WPP agency based in New York City, he led production efforts for multiple offices across the U.S. creating digital content and experiences for clients including P&G, the Intercontinental Hotel Group, Microsoft and many others. Prior to POSSIBLE, Hutten founded Sequel Media, a boutique digital media production shop to develop innovative media solutions for healthcare clients.

jess round.png

Jessica Federer, MPH
Strategy and Partnerships

Jessica is the former Chief Digital Officer at Bayer Pharmaceutical. Within Bayer, she also held positions in Global Regulatory Affairs, Market Access, Communications and Public Affairs. She is recognized as one of the top 100 global CDOs, a "Power-Lady" of the German economy, and a leading Health Tech Influencer. She serves as an advisor for private technology companies, and is on the m-Powering Development Advisory Board for the UN Agency for Information and Communications Technology (ITU).